Requirement for expert histopathological assessment of ovarian cancer and borderline tumours

The distinction between borderline ovarian tumours (BOT) and ovarian carcinoma is made by histopathological assessment. Of 64 patients managed according to institutional BOT protocols, 27 (42%) had been referred with a diagnosis of ovarian carcinoma that was subsequently changed to BOT following his...

Descripción completa

Detalles Bibliográficos
Autores principales: Sengupta, P S, Shanks, J H, Buckley, C H, Ryder, W D J, Davies, J, Reynolds, K, Slade, R J, Kitchener, H C, Jayson, G C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374382/
https://www.ncbi.nlm.nih.gov/pubmed/10732741
http://dx.doi.org/10.1054/bjoc.1999.0994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374382/
https://www.ncbi.nlm.nih.gov/pubmed/10732741
http://dx.doi.org/10.1054/bjoc.1999.0994

Ejemplares similares